Study Finds Medtronic Insertable Cardiac Monitors Detect Atrial Fibrillation In Stroke Patients Better Than Standard Care

[at noodls] – MINNEAPOLIS – February 14, 2014 – Medtronic, Inc. (NYSE: MDT), today announced results from the CRYSTAL AF (CRYptogenic STroke And underLying Atrial Fibrillation) Clinical Trial, which found that continuous … more

View todays social media effects on MDT

View the latest stocks trending across Twitter. Click to view dashboard

See who Medtronic is hiring next, click here to view